Levide (Levosulpiride)

Levosulpiride acts as a selective antagonist of dopamine D2 receptors, reducing dopaminergic activity that contributes to psychotic symptoms. It also has serotonergic effects and stimulates cholinergic pathways in the gut, which together improve gastric emptying and alleviate dyspeptic complaints.

The dosage of Levide is individualized by the prescribing clinician based on the specific indication, patient age, renal and hepatic function, and treatment response. Healthcare professionals determine the appropriate strength and frequency, and patients should follow the prescriber’s instructions without self‑adjusting the dose.

Safety data for levosulpiride in pregnancy and lactation are limited. The drug should only be used when the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives and risk assessment with their healthcare provider.

To request Levide, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Levide (levosulpiride) belongs to the benzamide class, offering a distinct D2 antagonism profile with additional serotonergic activity. Compared with typical antipsychotics such as haloperidol, it may have a lower risk of severe extrapyramidal symptoms, while differing from atypical agents like risperidone in its pro‑kinetic gastrointestinal effects. Choice depends on clinical needs, side‑effect tolerance and individual patient response.

Levide should be stored at room temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments to maintain stability and potency.

Levide is taken orally, usually as a tablet swallowed with water. It can be taken with or without food, but patients should follow the prescribing clinician’s guidance regarding timing relative to meals to ensure consistent absorption.

The most serious adverse reactions to monitor include extrapyramidal symptoms such as dystonia or akathisia, hyperprolactinemia that may cause hormonal disturbances, and neuroleptic malignant syndrome, a rare but life‑threatening condition characterized by fever, muscle rigidity and autonomic instability. Prompt medical attention is required if any of these occur.

Levide is contraindicated in individuals with known hypersensitivity to levosulpiride or other benzamide antipsychotics. It should also be avoided in patients taking monoamine oxidase inhibitors, those with a history of severe cardiac arrhythmias, and anyone for whom dopamine antagonism is medically inadvisable, unless a specialist determines that benefits outweigh risks.